A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201

被引：38
|
作者：
Loehrer, P. J., Sr.
Powell, M. E.
Cardenes, H. R.
Wagner, L.
Brell, J. M.
Ramanathan, R. K.
Crane, C. H.
Alberts, S. R.
Benson, A. B., III
机构：
[1] Indiana Univ, Eastern Cooperat Oncol Grp, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Northwestern Univ, Chicago, IL 60611 USA
[4] Case Western Reserve Univ, Cleveland, OH 44106 USA
[5] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.4506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4506
引用
收藏
页数：1
相关论文
共 50 条
  • [1] E4201: Randomized phase II study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with locally advanced, unresectable, pancreatic cancer (LAPC): Quality-of-life (QOL) analysis
    Cardenes, H. R.
    Powell, M.
    Loehrer, P. J.
    Wagner, L. I.
    Cella, D. F.
    Brell, J.
    Ramanathan, R. K.
    Crane, C. H.
    Alberts, S. R.
    Benson, A. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer
    Epelbaum, R
    Rosenblatt, E
    Nasrallah, S
    Faraggi, D
    Gaitini, D
    Mizrahi, S
    Kuten, A
    JOURNAL OF SURGICAL ONCOLOGY, 2002, 81 (03) : 138 - 143
  • [3] A Phase II Study of Gemcitabine in Combination With Radiation Therapy in Patients With Localized, Unresectable, Pancreatic Cancer A Hoosier Oncology Group Study
    Cardenes, Higinia R.
    Moore, Annette M.
    Johnson, Cynthia S.
    Yu, Menggang
    Helft, Paul
    Chiorean, Elena G.
    Vinson, Jacob
    Howard, Thomas J.
    Stephens, Anthony W.
    Tai, D. Fritz
    Loehrer, Patrick J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (05): : 460 - 465
  • [4] A randomized phase II study of gemcitabine plus S-1 versus gemcitabine alone in patients with unresectable pancreatic cancer.
    Omuro, Y.
    Ikari, T.
    Ishii, H.
    Ozaka, M.
    Suyama, M.
    Matsumura, Y.
    Itoi, T.
    Egawa, N.
    Yano, S.
    Hanada, K.
    Kimura, Y.
    Ukita, T.
    Ishida, Y.
    Tani, M.
    Ohoka, S.
    Hirose, Y.
    Hijioka, S.
    Watanabe, R.
    Ikeda, T.
    Nakajima, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] A randomized phase III study of irinotecan/gemcitabine combination versus gemcitabine in patients with advanced/metastatic pancreatic cancer.
    Stathopoulos, GP
    Aravantinos, G
    Syrigos, K
    Kalbakis, K
    Karvounis, N
    Papakotoulas, P
    Boukovinas, J
    Potamianou, A
    Polyzos, A
    Christophilakis, CH
    Georgoulias, V
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 334S - 334S
  • [6] A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: A Hoosier Oncology Group Trial.
    Moore, AM
    Cardenes, H
    Johnson, CS
    Helft, P
    Seitz, D
    Stephens, A
    Tai, DF
    Loehrer, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 339S - 339S
  • [7] A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
    Oettle, H
    Richards, D
    Ramanathan, RK
    van Laethem, JL
    Peeters, M
    Fuchs, M
    Zimmermann, A
    John, W
    Von Hoff, D
    Arning, M
    Kindler, HL
    ANNALS OF ONCOLOGY, 2005, 16 (10) : 1639 - 1645
  • [8] Phase II study of gemcitabine (GEM) combined with radiation therapy (RT) in localized, unresectable pancreatic cancer
    Epelbaum, R
    Rosenblatt, E
    Nasrallah, S
    Menashe, N
    Yardeni, T
    Faraggi, D
    Kuten, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S148 - S149
  • [9] Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer
    Abou-Alfa, Ghassan K.
    Letourneau, Richard
    Harker, Graydon
    Modiano, Manuel
    Hurwitz, Herbert
    Tchekmedyian, Nerses Simon
    Feit, Kevie
    Ackerman, Judie
    De Jager, Robert L.
    Eckhardt, S. Gail
    O'Reilly, Eileen M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4441 - 4447
  • [10] Randomized controlled trial of gemcitabine in combination with UFT versus gemcitabine alone in patients with advanced pancreatic cancer.
    Ohkawa, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 346S - 346S
12345